MEBO-DFU再生疗法治疗糖尿病足临床研究进展

Progress of Clinical Study on the Treatment of Diabetic Foot with MEBO-DFU Regenerative Therapy

近年来,糖尿病足的发病率呈现出快速上升的趋势,但其治疗仍是世界性难题。20余年的临床实践和基础研究证实,MEBO-DFU再生疗法治疗糖尿病足的疗效确切,该疗法能够为创面营造生理性湿润环境、液化排除坏死组织、减轻疼痛、防治感染、促进创面新生血管的形成和成熟、恢复患处神经功能,最终实现创面的生理性再生复原,不仅显著提高了糖尿病足溃疡创面的愈合率,而且还大大降低了截肢率。MEBO-DFU再生疗法治疗糖尿病足主要强调及时而规范的应用原则,尤其是规范应用至关重要。

The occurrence of diabetic foot has been increasing fast in the past few years, however, the treatment of diabetic foot remains a worldwide challenge. Through over 20 years of clinical practice and basic studies, applying MEBO-DFU regenerative therapy to treat diabetic foot has been proved reliable in curative effect. This therapy is able to generate a physi-ologically moist environment for wound healing, liquefy and discharge the necrotic tissues, relieve pains, prevent infections, promote neovascularization and vessel maturation and regain neural functions, and eventually achieve physiological regenera-tive restoration of the wound site. This therapy not only significantly improves the healing rate of ulcer wound of diabetic foot, but prominently reduces the amputation rate. MEBO-DFU regenerative therapy in treatment of diabetic foot mainly em-phasize the principle of timely and standard application, wherein standard application is particularly crucial.